Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat

Radiation Research

Volumn 145, Issue 4, 1996, Pages 449-456

  Belinsky, Steven A ^a   Middleton, Susan K ^a   Picksley, Steven M ^b   Hahn, Fletcher F ^a   Nikula, Kristen J ^a  

^a Inhalation Toxicology Research Institute   (United States)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL EXPERIMENT; ARTICLE; CANCER RISK; ELECTROPHORETIC MOBILITY; GENE MUTATION; LUNG ADENOCARCINOMA; LUNG TUMOR; NONHUMAN; ONCOGENE K RAS; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RAT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA; X RAY;

ADENOCARCINOMA; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA PRIMERS; FEMALE; GENE AMPLIFICATION; GENES, P53; GENES, RAS; HUMANS; LUNG NEOPLASMS; MALE; MICE; MOLECULAR SEQUENCE DATA; NEOPLASMS, RADIATION-INDUCED; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; PROTO-ONCOGENE PROTEINS C-RAF; PROTO-ONCOGENE PROTEINS P21(RAS); RATS; RATS, INBRED F344; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR SUPPRESSOR PROTEIN P53; X-RAYS;

ANIMALIA;

EID: 0029917614     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579066     Document Type: Article

References (49)

1. L. H. Breimer, Ionizing radiation-induced mutagenesis. Br. J. Cancer 57, 6-18 (1988).
2. T. Ishimaru, R. W. Cihak, C. E. Land, A. Steer and A. Yamada, Lung cancer at autopsy in A-bomb survivors and controls. Hiroshima and Nagasaki, 1961-1970. II. Smoking, occupation, and A-bomb exposure. Cancer 36, 1723-1728 (1975).
3. J. K. Wagoner, V. E. Archer, F. E. Lundin, Jr., D. A. Holaday and J. W. Lloyd, Radiation as a cause of lung cancer among uranium miners. N. Engl. J. Med. 273, 181-188 (1965).
4. A. F. List, D. C. Foil and F. A. Greco, Lung cancer and Hodgkin's disease: Association with previous radiotherapy. J. Clin. Oncol. 3, 215-221 (1985).
5. C. A. Hill, L. B. North and P. N. Osborne, Bronchogenic carcinoma in breast carcinoma patients. Am. J. Roentgenol. 140, 259-264 (1983).
6. A. J. Grosovsky, J. G. de Boer, P. J. de Jong, E. A. Drobetsky and B. W. Glickman, Base substitutions, frameshifts, and small deletions constitute ionizing radiation-induced point mutations in mammalian cells. Proc. Natl. Acad. Sci. USA 85, 185-188 (1988).
7. S. L. Nelson, C. R. Giver and A. J. Grosovsky, Spectrum of X-ray-induced mutations in the human hpri gene. Carcinogenesis 15, 495-502 (1994).
8. C. R. Giver, S. L. Nelson, M. Y. Cha, P. Pongsaensook and A. J. Grosovsky, Mutational spectrum of X-ray induced TK human cell mutants. Carcinogenesis 16, 267-275 (1995).
9. J. Yuan, T. M. Yeasky, M. C. Rhee and P. M. Glazer, Frequent T:A → G:C transversions in X-irradiated mouse cells. Carcinogenesis 16, 83-88 (1995).
10. M. S. Greenblatt, W. P. Bennett, M. Hollstein and C. C. Harris, Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878 (1994).
11. D. E. Brash, J. A. Rudolph, J. A. Simon, A. Lin, G. J. McKenna, H. P. Baden, A. J. Halperin and J Pontén, A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 88, 10124-10128 (1991).
12. J. A. Taylor, M. A. Watson, T. R. Devereux, R. Y. Michels, G. Saccomanno and M. Anderson. p53 mutation hotspot in radon-associated lung cancer. Lancet 343, 86-87 (1994).
13. B. L. Stegelmeier, N. A. Gillett, A. H. Rebar and G. Kelly, The molecular progression of plutonium-239-induced rat lung Carcinogenesis. Mol. Carcinogenesis 4, 43-51 (1991).
14. M. Barbacid, ras Genes. Annu. Rev. Biochem. 56, 779-827 (1987).
15. M. Hollstein, D. Sidransky, B. Vogelstein and C. C. Harris, p53 mutations in human cancers. Science 253, 49-53 (1991).
16. J. Marx, Forging a path to the nucleus. Science 260, 1588-1590 (1993).
17. J. Avruch, X. Zhang and J. M. Kyriakis, Raf meets ras: Completing the framework of a signal transduction pathway. Trends Biochem. Sci. 19, 279-283 (1994).
18. S. M. Storm and U. P. Rapp, Oncogene activation: c-raf-1 mutations in experimental and naturally occurring tumors. Toxicol. Lett. 67, 201-210 (1993).
19. J. D. Oliner, K. W. Kinzler, P. S. Meltzer, D. L. George and B. Vogelstein, Amplification of a gene encoding a p53-associated protein in human sarcomas Nature 358, 80-83 (1992).
20. T. Juven, Y. Barak, A. Zauber, D. George and M. Oren, Wild type p53 can mediate sequence-specific transactivation of an internal promoter with the mdm2 gene. Oncogene 8, 3411-3416 (1993).
21. W. S. El-Deiry, T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler and B. Vogelstein, WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
22. C. Cordon-Cardo, E. Latres, M. Drobnjak, M. R. Oliva, D. Pollack, J. M. Woodruff, V. Marechal, J. Chen, F. F. Brennan and A. J. Levine, Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res. 54, 794-799 (1994).
23. J. Momand, G. P. Zambetti, D. C. Olson, D. George and A. J. Levine, The mdm2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245 (1992).
24. F. F. Hahn, D. L. Lundgren, W. C. Griffith and B. B. Boecker, Effects of thoracic and whole body exposure of F344 rats to X rays. In Inhalation Toxicology Research Institute Annual Report 1992-1993, pp. 64-65. Report ITRI 140, National Technical Information Service, Springfield, VA, 1993.
25. J. A. Marmur, A procedure for isolation of deoxyribonucleic acid from microorganisms. J. Mol. Biol. 3, 208-218 (1961).
26. S. Levi, A. Urbano-Ispizua, R. Gill, D. M. Thomas, T. J. Gilbertson, C. Foster and C. J. Marshall, Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res. 51, 3497-3502 (1991).
27. K. Huppi, D. Siwarski, J. Dosik, P. Micheili, M. Chedid, S. Reed, B. Mock, D. Givol and J. F. Mulshinski, Molecular cloning, sequencing, chromosomal localization and expression of mouse p21 (Waf1). Oncogene 9, 3017-3020 (1994).
28. C. Nickell-Brady, F. F. Hahn, G. L. Finch and S. A. Belinsky, Analysis of K-ras. p53 and c-raf-1 mutations in beryllium-induced rat lung tumors. Carcinogenesis 15. 257-262 (1994).
29. D. S. Swafford, K. J. Nikula, C. E. Mitchell and S. A. Belinsky, Low frequency of alterations in p53, K-ras. and mdm2 in rat lung neoplasms induced by diesel exhaust or carbon black. Carcinogenesis 16, 1215-1221 (1995)
30. J. E. Hulla and R. P. Schneider, Structure of the rat p53 tumor suppressor gene. Nucleic Acids Res. 21, 713-717 (1993).
31. M. Orita, H. Iwahana, H. Kanazawa, K. Hayashi and T. Sekiya, Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA 86, 2766-2770 (1989).
32. S. M. Kahn, W. Jiang, T. A. Culbertson, I. B. Weinstein, G. M. Williams, N. Tomita and Z. Ronai, Rapid and sensitive nonradioactive detection of mutant K-ras genes via "enriched" PCR amplification. Oncogene 6, 1079-1083 (1991).
33. F. S. Leach, T. Tokino, P. Meltzer, M. Burrell, J. D. Oliner, S. Smith. D. E. Hill, D. Sidransky, K. W. Kinzler and B. Vogelstein, p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res. 53, 2231-2234 (1993).
34. S. M. Picksley, B. Vojtesek, A. Sparks and D. P. Lane, Immunochemical analysis of the interaction of p53 with MDM2; - fine mapping of the MDM2 binding site on p53 using synthetic peptides. Oncogene 9, 2523-2529 (1994).
35. Y. Barak, T. Juvea, R. Haffner and M. Oren, mdm2 expression is induced by wild type p53 activity. EMBO J. 12, 461-468 (1993).
36. S. W. C. Leuthauser, J. E. Thomas and D. L. Guernsey, Oncogenes in X-ray-transformed C3H 10T1/2 mouse cells and in X-ray-induced mouse fibrosarcoma (RIF-1) cells. Int. J. Radiat. Biol. 62, 45-51 (1992).
37. C. Borek, A. Ong and H. Mason, Distinctive transforming genes in X-ray-transformed mammalian cells. Proc. Natl. Acad. Sci. USA 84, 794-798 (1987).
38. A. W. Hickman, R. J. Jaramillo, J. F. Lechner and N. F. Johnson, α-Particle-induced p53 protein expression in a rat lung epithelial cell strain. Cancer Res. 54, 5797-5800 (1994).
39. R. A. Herbert, N. A. Gillett, A. H. Rebar, D. L. Lundgren, M. D. Hoover, I. Y. Chang, W. W. Carlton and F. F. Hahn, Sequential analysis of the pathogenesis of plutonium-induced pulmonary neoplasms in the rat: Morphology, morphometry, and cytokinetics Radiat. Res. 134, 29-42 (1993).
40. G. Kelly, B. L. Stegelmeier and F. F. Hahn, p53 alterations in plutonium-induced F344 rat lung tumors. Radiat. Res. 142, 263-269 (1995).
41. Y. Takeshima, T. Seyama, W. P. Bennett, M. Akiyama, S Tokuoka, K. Inaj, K. Mabuchi, C. E. Land and C. C. Harris, p53 mutations in lung cancers from non-smoking atomic-bomb survivors. Lancet 342, 1520-1521 (1993).
42. T. A. Lehman, W. P. Bennett, R. A. Metcalf, J. A. Welsh, J. Ecker. R. V. Modali, S. Ullrich, J. W. Romane, E. Appella, J. R. Testa, B. I Gerwin and C. C. Harris. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res. 51, 4090-4096 (1990).
43. R. M. Elledge, G. M. Clark, S. A. W. Fuqua, Y-Y. Yu and D. C. Allred. p53 protein accumulation detected by five different antibodies: Relationship to prognosis and heat shock protein 70 in breast cancer Cancer Res. 54, 3752-3757 (1994).
44. K. J. Cripps, P. J. Purdie, S. White, K. Komine, C. C. Bird and A. H. Wyllie, A study of stabilization of p53 protein versus point mutation in colorectal carcinoma. Oncogene 9, 2739-2743 (1994).
45. J. E. Landers, D. S. Haines, J. F. Strauss and D. L. George, Enhanced translation: A novel mechanism of mdm2 oncogene overexpression identified in human tumor cells. Oncogene 9, 2745-2750 (1994).
46. J. W. Harper, G. R. Adami, N. Wei, K. Keyomarsi and S. J. Elledge, The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816 (1993).
47. Y. Sun, Z. Dong, J. Jackman, G. Hegamyer, H. Kim, K. Sithanandam and N. H. Colburn, Status of the MDM-2 and WAF-1 genes in mouse epidermal JB6 variants harboring wild-type p53: A p53-independent induction of WAF-1. Int. J. Oncol. 6, 465-471 (1995).
48. A. Kamb, N. A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S. V Tavtigian, E. Stockert, R. S. Day, B. E. Johnson and M. H. Skolnick, A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436-440 (1994).
49. S. Hosoe, Y. Shigedo, K. Ueno, I. Tachibana, T. Osaki, Y. Tanio, I. Kawase, K. Yamakawa, Y. Nakamura and T. Kishimoto, Detailed deletion mapping of the short arm of chromosome 3 in small cell and non-small cell carcinoma of the lung. Lung Cancer 10. 297-305 (1994)